These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28093482)

  • 21. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
    Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
    J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Characterization of ST195 and ST365 Carbapenem-Resistant Acinetobacter baumannii Harboring blaOXA-23 in Guangzhou, China.
    Zhou Y; Wu X; Zhang X; Hu Y; Yang X; Yang Z; Wang M
    Microb Drug Resist; 2015 Aug; 21(4):386-90. PubMed ID: 25602500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis.
    Pedraza R; Kieffer N; Guzmán-Puche J; Artacho MJ; Pitart C; Hernández-García M; Vila J; Cantón R; Martinez-Martinez L
    J Antimicrob Chemother; 2022 Oct; 77(11):3009-3015. PubMed ID: 35971566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
    Lu PL; Doumith M; Livermore DM; Chen TP; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):641-7. PubMed ID: 19182237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital.
    Protonotariou E; Poulou A; Politi L; Meletis G; Chatzopoulou F; Malousi A; Metallidis S; Tsakris A; Skoura L
    Int J Antimicrob Agents; 2020 Aug; 56(2):106060. PubMed ID: 32574790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain.
    Oteo J; Hernández JM; Espasa M; Fleites A; Sáez D; Bautista V; Pérez-Vázquez M; Fernández-García MD; Delgado-Iribarren A; Sánchez-Romero I; García-Picazo L; Miguel MD; Solís S; Aznar E; Trujillo G; Mediavilla C; Fontanals D; Rojo S; Vindel A; Campos J
    J Antimicrob Chemother; 2013 Feb; 68(2):317-21. PubMed ID: 23034714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel genetic context of multiple bla OXA-58 genes in Acinetobacter genospecies 3.
    Evans BA; Hamouda A; Towner KJ; Amyes SG
    J Antimicrob Chemother; 2010 Aug; 65(8):1586-8. PubMed ID: 20542900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales.
    Bonnin RA; Girlich D; Jousset AB; Gauthier L; Cuzon G; Bogaerts P; Haenni M; Madec JY; Couvé-Deacon E; Barraud O; Fortineau N; Glaser P; Glupczynski Y; Dortet L; Naas T
    Sci Rep; 2020 Jun; 10(1):9160. PubMed ID: 32514057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region.
    Siebor E; Neuwirth C
    J Antimicrob Chemother; 2011 Nov; 66(11):2513-20. PubMed ID: 21846670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Pournaras S; Markou F
    J Antimicrob Chemother; 2007 Jul; 60(1):136-9. PubMed ID: 17491004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility and beta-lactamase production of selected gram-negative bacilli from two Croatian hospitals: MYSTIC study results.
    Bedenic B; Goic-Barisic I; Budimir A; Tonkic M; Mihajkevic LJ; Novak A; Sviben M; Plecko V; Punda-Polic V; Kalenic S
    J Chemother; 2010 Jun; 22(3):147-52. PubMed ID: 20566417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ISAba825 controls the expression of the chromosomal bla(OXA-51-like) and the plasmid borne bla(OXA-58) gene in clinical isolates of Acinetobacter baumannii isolated from the USA.
    Lopes BS; Al-Hassan L; Amyes SG
    Clin Microbiol Infect; 2012 Nov; 18(11):E446-51. PubMed ID: 22862829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.
    Dortet L; Oueslati S; Jeannot K; Tandé D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3823-8. PubMed ID: 25870062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
    Pfeifer Y; Wilharm G; Zander E; Wichelhaus TA; Göttig S; Hunfeld KP; Seifert H; Witte W; Higgins PG
    J Antimicrob Chemother; 2011 Sep; 66(9):1998-2001. PubMed ID: 21693460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.